
Erythromycin is a premium-grade, broad-spectrum macrolide active pharmaceutical ingredient (API) with CAS number 114-07-8. This high-purity antibacterial compound is widely utilized across the global healthcare sector to manufacture clinical-strength oral tablets, topical anti-acne solutions, ophthalmic ointments, and advanced veterinary medicine runs.
Exceptional digestibility and rapid absorption provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically binding reversibly to the 50S ribosomal subunits of susceptible microorganisms to inhibit protein synthesis—needed for effective systemic modulation. It helps manufacturers achieve potent therapeutic profiles in anti-infective products without sacrificing formula stability. For instance, Erythromycin is frequently used as a primary ingredient in clinical-strength respiratory and soft tissue therapies. Consequently, it improves the clinical efficacy of acute bacterial infection management routines. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized fine powder grades for the veterinary medicine and livestock care industries. This compound acts as a critical structural asset, helping to enhance the defense mechanisms of biological systems undergoing severe microbial exposure. It pushes the boundaries of medical science by offering a highly stable active source that does not affect the final solution’s processing parameters during enteric coating processes. At the same time, it serves as a crucial biomaterial matrix in the synthesis of specialized combination therapies and chemical drug intermediates. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of modern biomedical engineering.
This high-purity broad-spectrum macrolide active is essential in these four primary sectors:
Primary active source for manufacturing film-coated oral tablets, capsules, and pediatric suspensions. Thus, it provides essential support for systemic microbial control.
Key drug ingredient utilized for topical anti-acne lotions, solutions, and anti-inflammatory ointments. Undoubtedly, it is vital for enhancing targeted dermal stabilization benchmarks.
Used as a professional treatment active for respiratory disease management in poultry and aquaculture. Consequently, it is vital for high-performance animal recovery.
Acts as an essential reference active for bacterial translation blocking studies and laboratory trials. Specifically, it supports rapid data compilation and assay safety.
| Parameter | Standard Value |
|---|---|
| Product Name | Erythromycin (USP / BP / EP Pharmaceutical Grade) |
| Assay / Purity | 930 μg/mg – 1020 μg/mg (Calculated on Anhydrous Basis) |
| Appearance | White or slightly yellow crystalline powder |
| Specific Rotation | -71° to -78° |
| Water Content | ≤ 10.0% |
| CAS Number | 114-07-8 |
📝 Safety & Handling: Formulated strictly for controlled pharmaceutical manufacturing, antibiotic compounding, and clinical laboratory workflows. Erythromycin is a potent macrolide agent that is highly sensitive to acidic environments, which cause rapid molecular degradation. Occupational exposure may cause mild skin irritation, gastrointestinal discomfort upon accidental ingestion, or localized respiratory tract sensitivity. Therefore, store in a cool, dry location below 25°C, completely protected from direct light, localized moisture, and strong oxidizing or acidic materials in its original safety-sealed containers. Prevent excessive dust generation during large-scale blending lines to maintain full potency and protect operators. Wearing basic laboratory protective equipment (PPE)—including chemical-resistant gloves, safety goggles, and a standard dust mask—is recommended during material handling. Always consult the Safety Data Sheet (SDS) for detailed protocols.